As of 2026-02-04, AI驱动的药物研发数字孪生模型's data on the DeepSeek platform in the 生物医药数字化科研协作平台 category shows: The overall mention rate is 0.00%, above the industry average by 0.0 percentage points, showing notable performance. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
AI驱动的药物研发数字孪生模型's Mention Rate is 0.00%, lower than 0.6% of competitors
AI驱动的药物研发数字孪生模型's First Mention is 0.00%, lower than 0.9% of competitors
AI驱动的药物研发数字孪生模型's Preferred Rate is 0.00%, lower than 100.0% of competitors
AI驱动的药物研发数字孪生模型's Positive Rate is 0.00%, lower than 8.9% of competitors
AI驱动的药物研发数字孪生模型's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| AAI驱动的药物研发数字孪生模型 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
